TLSI
Income statement / Annual
Last year (2025), TriSalus Life Sciences Inc's total revenue was $45.15 M,
an increase of 53.41% from the previous year.
In 2025, TriSalus Life Sciences Inc's net income was -$39.23 M.
See TriSalus Life Sciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$45.15 M |
$29.43 M |
$18.51 M |
$12.40 M |
$8.40 M |
$0.00 |
| Cost of Revenue |
$6.97 M
|
$4.10 M
|
$2.61 M
|
$2.26 M
|
$1.19 M
|
$0.00
|
| Gross Profit |
$38.19 M
|
$25.33 M
|
$15.91 M
|
$10.14 M
|
$7.21 M
|
$0.00
|
| Gross Profit Ratio |
0.85
|
0.86
|
0.86
|
0.82
|
0.86
|
0
|
| Research and Development Expenses |
$14.97 M
|
$17.69 M
|
$29.84 M
|
$21.36 M
|
$14.22 M
|
$0.00
|
| General & Administrative Expenses |
$21.46 M
|
$17.97 M
|
$23.51 M
|
$12.48 M
|
$8.75 M
|
$0.00
|
| Selling & Marketing Expenses |
$28.71 M
|
$25.84 M
|
$17.03 M
|
$12.74 M
|
$8.26 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$50.17 M
|
$43.81 M
|
$40.55 M
|
$25.22 M
|
$17.02 M
|
$108.49 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$65.13 M
|
$61.49 M
|
$70.38 M
|
$46.58 M
|
$31.24 M
|
$108.49 K
|
| Cost And Expenses |
$72.10 M
|
$65.60 M
|
$72.99 M
|
$48.84 M
|
$32.43 M
|
$108.49 K
|
| Interest Income |
$555.00 K
|
$404.00 K
|
$431.00 K
|
$180.00 K
|
$0.00
|
$3.30 K
|
| Interest Expense |
$5.54 M
|
$3.09 M
|
$16.00 K
|
$1.00 K
|
$1.76 M
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$3.04 M
|
$684.00 K
|
$414.00 K
|
$464.00 K
|
$0.00
|
| EBITDA |
-$26.95 M |
-$36.17 M |
-$58.65 M |
-$46.76 M |
-$23.57 M |
-$711.39 K |
| EBITDA Ratio |
-0.6
|
-1.23
|
-3.17
|
-3.77
|
-2.81
|
0
|
| Operating Income Ratio |
-0.6
|
-1.23
|
-2.94
|
-2.94
|
-2.86
|
0
|
| Total Other Income/Expenses Net |
-$12.27 M
|
$6.13 M
|
-$4.88 M
|
-$10.74 M
|
-$4.81 M
|
-$602.90 K
|
| Income Before Tax |
-$39.22 M
|
-$30.04 M
|
-$59.35 M
|
-$47.18 M
|
-$28.84 M
|
-$711.39 K
|
| Income Before Tax Ratio |
-0.87
|
-1.02
|
-3.21
|
-3.81
|
-3.43
|
0
|
| Income Tax Expense |
$7.00 K
|
$6.00 K
|
$9.00 K
|
$9.00 K
|
$3.00 K
|
$0.00
|
| Net Income |
-$39.23 M
|
-$33.23 M
|
-$59.36 M
|
-$47.19 M
|
-$28.85 M
|
-$31.83 M
|
| Net Income Ratio |
-0.87
|
-1.13
|
-3.21
|
-3.81
|
-3.43
|
0
|
| EPS |
-1.84 |
-1.25 |
-2.23 |
-1.59 |
-0.92 |
-0.0228 |
| EPS Diluted |
-1.84 |
-1.25 |
-2.23 |
-1.59 |
-0.92 |
-0.0228 |
| Weighted Average Shares Out |
$37.90 M
|
$26.50 M
|
$26.47 M
|
$29.61 M
|
$31.25 M
|
$30.56 M
|
| Weighted Average Shares Out Diluted |
$37.90 M
|
$26.50 M
|
$26.47 M
|
$29.61 M
|
$31.25 M
|
$30.56 M
|
| Link |
|
|
|
|
|
|
